Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

Clinical trial NCT00070070 · COMPLETED

Trial details

NCT number: NCT00070070
Sponsor: Ludwig Institute for Cancer Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Transitional Cell Carcinoma

Start date: 2003-10-28
Primary completion: 2006-01-03
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.